Says “significant opportunities” in Medicare Advantage business. Says “encouraged by progress” in Aetna business. Says “strong momentum” heading into 2025. Comments taken from Q4 earnings conference call.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS Health sees FY25 CapEx $2.8B-$3B
- CVS Health says FY25 guidance ‘reflects an appropriately achievable baseline’
- CVS Health sees FY25 revenue ‘at least’ $385.9B, consensus $386.49B
- Options Volatility and Implied Earnings Moves Today, February 12, 2025
- CVS Earnings: CVS Health Stock Jumps as Earnings Beat Despite Higher Insurance Payouts